FDA.reportPublic FDA data

fostamatinib 100 MG (equivalent to fostamatinib disodium 126.2 MG ) Oral Tablet

RxCUI
2044922
RxNorm name
fostamatinib 100 MG (equivalent to fostamatinib disodium 126.2 MG ) Oral Tablet
Display name
fostamatinib 100 MG (equivalent to fostamatinib disodium 126.2 MG ) Oral Tablet
Full name
fostamatinib 100 MG (equivalent to fostamatinib disodium 126.2 MG ) Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TAVALISSEFOSTAMATINIBRigel Pharmaceuticals, Inc.21149cc3-049b-43e2-b141-c9499160556c2025-11-05Warnings, Adverse reactionsExact identifier
rxcui: 2044922

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
21149cc3-049b-43e2-b141-c9499160556cfostamatinib 100 MG Oral Tablet [PSN] · fostamatinib 100 MG Oral Tablet [SCD] · fostamatinib 100 MG (equivalent to fostamatinib disodium 126.2 MG ) Oral Tablet [SY]311These highlights do not include all the information needed to use TAVALISSE ® safely and effectively. See full prescribing information for TAVALISSE. TAVALISSE ® (fostamatinib disodium hexahydrate) tablets, for oral use Initial U.S. Approval: 201820251105